Tag: Aimmune Therapeutics

Nestle Acquires Aimmune

Nestlé Acquires Aimmune, Partners with Enterome to Develop Food Allergy and...

Nestlé, the consumer products powerhouse, is expanding its pharmaceutical portfolio with massive investments.
AIM_Palforzia_SnackSafely_Article_Holiday_imagesFamily

This Holiday Season, See the Potential Impact that Peanut Allergy Treatment...

Did you know there’s a treatment option in addition to avoidance alone?

Notebooks, check. Backpack, check. Peanut allergy treatment, check. (Sponsored)

What if you could give your child a treatment option, in addition to practicing a strict peanut-free diet?
Palforzia Capsules with Logo

Study: More Than 80% of Patients Could Tolerate 2000mg of Peanuts...

Safety and efficacy increased over time with treatment.
Oral Food Challenge

FARE Launches Global Research Competition to Develop a Safe, Compassionate Diagnostic...

$3 Million in prize money will inspire the world's leading food allergy researchers to put an end to the oral food challenge.
Palforzia Capsules with Logo

Aimmune Presents New Clinical Data From Patients Treated With PALFORZIA® for...

Majority of patients experienced low rates of adverse events which declined in frequency and severity with continued treatment.
Nestle Acquires Aimmune

Nestlé to Acquire Aimmune Therapeutics

Nestlé Health Science and Aimmune to create a global leader in food allergy prevention and treatment.
Upset Teen

Study Shows Negative Impact of Avoidance and Fear of Accidental Reactions...

The psychosocial impact of food allergies on children and teens is severe.
Palforzia

New Two-Year PALFORZIA™ Data Show On-going Safety and Efficacy and Continued...

After 2 Years of Daily Treatment, More Than 80% of Patients Were Successfully Desensitized to 2000 mg Peanut Protein or Equivalent of About 14 Peanut Kernels.
Palforzia Capsules with Logo

Aimmune Warns Coronavirus Will Slow Marketing of Palforzia Treatment for Peanut...

The company warned that it has had to postpone in-person workshops to train physicians.